Conventional T cells (Tconvs) and WT or gene-deficient Tregs were transferred into Cd3ε−/− mice 4 days before anti-GBM antibody administration, and key indicators were examined 28 days after disease induction (see Fig. 4a). The gene discussed is CD3E; the disease is glioblastoma.